Biomedicine & Pharmacotherapy (Jan 2019)

FS-7 inhibits MGC-803 cells growth in vitro and in vivo via down-regulating glycolysis

  • Xiangping Deng,
  • Zhongli Li,
  • Runde Xiong,
  • Juan Liu,
  • Renbo Liu,
  • Junmei Peng,
  • Yanming Chen,
  • Xiaoyong Lei,
  • Xuan Cao,
  • Xing Zheng,
  • Zhizhong Xie,
  • Guotao Tang

Journal volume & issue
Vol. 109
pp. 1659 – 1669

Abstract

Read online

In this study, we investigated the anticancer effects of FS-7, a flavonoid salicylate derivative, in human gastric carcinoma MGC-803 cell line and studied its preliminary anticancer effects. FS-7 displayed greater in vitro cytotoxicity against MGC-803 cell line compared with 5-Fu and had a certain extent of selectivity to cancer cells. The flow cytometry analysis revealed that FS-7 induced apoptosis MGC-803 cells and mainly caused cells arrest in the G2/M phase in a concentration-dependent manner. Additionally, FS-7 inhibited the colony formation and cell migration in a concentration-dependent manner. Notably, FS-7 noticeably down-regulated glycolysis-related protein HIF-1α, HK-II and PFKP expression in a concentration-dependent manner, possibly causing glycolysis inhibition. Importantly, compared with 5-Fu, FS-7 showed better anticancer activity in the MGC-803 xenograft murine tumor models. Collectively, the present study provided a promising anticancer drug candidate for gastric cancer therapy.

Keywords